fastr: Finding Answers, Shortening Time to Recognition
In today's healthcare ecosystem, it is taking too long to diagnose rare disease. AERI Insights are speeding that up!
- Focused on real-world epidemiology, disease signals, biomarker usage, and other insights to speed time to diagnosis, and clinical management patterns in adult and pediatric populations with rare or underdiagnosed diseases.
- A multi-source, retrospective deep-dive data analysis initiative to understand, predict, and understand signals and risk for EDS, POTS, MAST, and other rare diseases.
- Integrates EHR and open and closed claims data to investigate symptom signals, biomarkers, and regimen-level predictors of irAE expression in cancer patients.
- Leverages a single and multi-center data sources to establish patient and/or prescriber cohorts
- Includes collaboration with leading clinicians and operational co-leads to guide translational relevance.
- Aims to establish foundational evidence for early detection tools and health system alerts, shortening the time to recognition and diagnosis for these fragile patients.